ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,312Medicare Part D Prescriptions Filled, Including Refills

Rank: 128 out of 633

$427K Total Retail Price of All Prescriptions

Rank: 145 out of 633

416 Patients Receiving at Least One Drug in Part D
85% Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nebraska
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

3% of this provider’s 416 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 416 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
OMEPRAZOLE 429 392 67 1 2
HYDROCODONE-ACETAMINOPHEN 387 258 57 S3 2 8
LISINOPRIL 289 284* 46 3 5
LEVOTHYROXINE SODIUM 284 279* 43 4 1
POTASSIUM CHLORIDE 260 237 36 5 11
SIMVASTATIN 237 232* 43 6 3
WARFARIN SODIUM 215 189 32 7 7
TRAMADOL HCL 201 181 31 8 15
HYDROCHLOROTHIAZIDE 192 180 28 9 14
METOPROLOL SUCCINATE 169 158 29 10 13
LOSARTAN POTASSIUM 167 162* 28 11 17
METOPROLOL TARTRATE 166 161* 27 12 12
FUROSEMIDE 164 145 24 13 6
METFORMIN HCL 161 136 28 14 10
ATENOLOL 123 118* 15 15 22
ZOLPIDEM TARTRATE 121 83 16 16 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 117 117 13 17 31
ATORVASTATIN CALCIUM 107 92 16 18 9
DIOVAN 98 98 11 19 52
TORSEMIDE 94 89* 15 20 110
GLIPIZIDE 93 69 15 21 82
CEPHALEXIN 92 81 58 22 72
ENALAPRIL MALEATE 91 73 14 23 42
PREDNISONE 88 83* 16 24 36
PROAIR HFA 88 48 12 24 76
GABAPENTIN 87 73 17 26 16
TAMSULOSIN HCL 77 77 17 27 24
ALLOPURINOL 75 70* 12 28 25
ALPRAZOLAM 71 26 13 B 29 32
CRESTOR 69 69 11 30 27
SERTRALINE HCL 69 56 11 30 19
AMLODIPINE BESYLATE 68 63* 20 32 4
CLONIDINE HCL 68 68 12 32 65
CREON 63 <11 <11 34 287
CLOPIDOGREL 58 <11 <11 35 30
CARVEDILOL 58 45 12 35 18
PREMARIN 57 <11 <11 R 37 150
LORAZEPAM 57 52* 12 B 37 37
JANUVIA 55 <11 <11 39 97
TRIAMTERENE-HCTZ 55 <11 <11 39 49
MELOXICAM 55 <11 <11 39 23
SYMBICORT 53 <11 <11 42 119
SPIRIVA 51 <11 <11 43 67
ROPINIROLE HCL 51 <11 <11 43 63
OLANZAPINE 51 <11 <11 A 43 123
FLUTICASONE PROPIONATE 51 40 11 43 39
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 2, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.